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ABSTRACT
Background It is well established that psychological
distress (depression and anxiety) is related to an
increased risk of mortality. The personality trait of
neuroticism, reﬂecting a relatively stable tendency
towards negative emotions, has also been associated
with elevated rates of death in some studies.
Accordingly, we tested the possibility that it is the
neuroticism trait itself, rather than the distress state, that
is generating an increased risk of mortality.
Methods We used data from the UK Biobank study, a
UK-wide prospective cohort study (2006–2010) in which
distress was ascertained using the Patient Health
Questionnaire and neuroticism using the Eysenck
Personality Questionnaire-Revised Short Form.
Results A mean of 6.2 years of follow-up of
308 721 study members gave rise to 4334 deaths.
Higher neuroticism was weakly associated with total
mortality (age-adjusted and sex-adjusted HR per SD
increase; 95% CI 1.05; 1.02 to 1.09), and moderately
strongly correlated with distress symptoms (r=0.55,
p<0.0001). Distress symptoms were positively related to
risk of total mortality (age-adjusted and sex-adjusted HR
per SD increase in distress; 95% CI 1.23; 1.20 to 1.26).
This gradient was, in fact, slightly strengthened after
adding neuroticism to the multivariable model (1.30;
1.26 to 1.34) but markedly attenuated after taking into
account other covariates which included health
behaviours and somatic disease (1.16; 1.12 to 1.20).
Similar results were apparent when cardiovascular
disease, cancer and external cause of death were the
end points of interest.
Conclusions While there was good a priori reasons to
anticipate the neuroticism would at least partially explain
the relation between distress symptoms and cause-
speciﬁc mortality, we found no such evidence in the
present study.
INTRODUCTION
Individual-participant and literature-based
meta-analyses reveal dose–response relationships
between higher levels of psychological distress
(depression/anxiety) and the risk of premature mor-
tality and selected chronic diseases.1–3 These observa-
tions have led to the speculation that treatment for
distress could usefully occur in individuals at lower
levels of distress than is currently recommended. The
personality trait of neuroticism, reﬂecting a relatively
stable tendency towards negative emotions, has also
been associated with elevated rates of death and car-
diovascular disease (CVD) in some studies.4 These
inter-relationships raise the possibility that it is the
neuroticism trait itself, rather than the distress
state, that is generating an elevated risk of mortality.
With no empirical examination of this hypothesis,
we assessed the impact of controlling for neuroticism
on the distress–mortality relation alongside a series
of more traditional explanatory variables, including
health behaviours.
METHODS
UK Biobank, a UK-wide, on-going, prospective
cohort study, has been described in detail.5 In brief,
between 2006 and 2010, 502 649 participants aged
37–73 years attended various geographically distrib-
uted research clinics. Members of the public visited
an assessment centre completed a questionnaire,
underwent an interview and took part in various
physical assessments. Ethical approval was obtained
from the National Health Service National Research
Ethics Service and all participants providing written
informed consent.
Assessment of psychological distress and
neuroticism
Psychological distress was measured using the four-
item version of the Patient Health Questionnaire
(PHQ-4).6 Items are rated on a four-point Likert
scale from 0 (not at all) to 3 (nearly every day)
such that possible total scores range from 0 to 12
(higher scores denote greater distress). Scores on
the PHQ-4 show good agreement with longer
scales, and correlate with demographic risk factors
for depression and anxiety.7 Neuroticism was mea-
sured with the 12-item Eysenck Personality
Questionnaire-Revised Short Form.8 Other covari-
ate data were collected using standard protocols,
including: health behaviours (smoking status,
alcohol intake, physical activity, dietary charac-
teristics), physical attributes (body mass index, sys-
tolic blood pressure, forced expiratory volume in
1 min, grip strength), existing disease (physician
diagnoses of vascular or heart problems, diabetes,
cancer, asthma, chronic lung disease, deep vein
thrombosis or pulmonary embolism at baseline)
and socioeconomic status (highest attained educa-
tional qualiﬁcation).
Study participants were linked to the National
Health Service’s Central Registry at Southport, UK,
which provided vital status data and, where applic-
able, cause of death. Having ascertained that the
proportional hazards assumption had been met, we
used Cox regression analyses with accompanying
95% CIs to summarise the association between psy-
chological distress and mortality experience. In our
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analyses, using the PHQ-4, psychological distress was cate-
gorised into three groups (score): 1 (0), 2 (1–2), 3 (≥3). The
selection of these categories was data driven: we wanted sufﬁ-
cient numbers of deaths in each distress category to conduct
robust statistical analyses.
RESULTS
In online supplementary table S1, we show the relation between
categories of the distress score and study member characteristics
at baseline. In general, people with a higher distress score had a
less favourable risk factor proﬁle as evidenced by poorer health
behaviours, a higher prevalence of chronic disease and elevated
neuroticism scores (r=0.55, p<0.0001). This was not a univer-
sal observation, however, in that levels of blood pressure and
alcohol intake were somewhat lower in study members reporting
a greater degree of distress.
A total of 308 721 people (142 983 women) had data on
distress, neuroticism, other potential confounding variables and
mortality. During a mean follow-up period of 6.2 years, 4334
people died. Table 1 shows the relation of distress scores with
total and cause-speciﬁc mortality. Irrespective of the mortality
outcome, there was a positive distress–death relationship such
that an elevated mortality risk was apparent in people with
higher distress scores. Higher neuroticism was weakly asso-
ciated with total mortality (age-adjusted and sex-adjusted HR
per SD (2.92) increase; 95% CI 1.05; 1.02 to 1.09), however,
in none of our analyses did controlling for neuroticism have
an attenuating impact on the distress–mortality end point asso-
ciations. Indeed, positive confounding, whereby the distress–
disease relationship was strengthened, was generally apparent.
In contrast, separate adjustment for each cluster of covariates
led to partial attenuation, with the greatest impact apparent for
health behaviours, irrespective of the outcome interest.
Controlling simultaneously for an additional 15 covariates led
to more marked attenuation of risk although a dose–response
association remained, as we illustrate for total mortality in
Table 1 HRs (95% CI) for psychological distress in relation to cause-specific mortality: UK Biobank (N=308 721)
Distress categories
1 (N=128 505) 2 (N=112 635) 3 (N=67 581)
p Value
for trend SD increase in distress
Total (4334 deaths)
Age-adjusted and sex-adjusted 1.0 (ref) 1.22 (1.14 to 1.31) 1.77 (1.64 to 1.91) <0.0001 1.23 (1.20 to 1.26)
Age-adjusted, sex-adjusted and neuroticism-adjusted 1.0 1.28 (1.19 to 1.38) 2.01 (1.84 to 2.20) <0.0001 1.30 (1.26 to 1.34)
Age-adjusted, sex-adjusted and health behaviours-adjusted 1.0 1.16 (1.09 to 1.25) 1.49 (1.38 to 1.61) <0.0001 1.14 (1.11 to 1.18)
Age-adjusted, sex-adjusted and physical attributes-adjusted 1.0 1.18 (1.10 to 1.27) 1.60 (1.48 to 1.72) <0.0001 1.18 (1.15 to 1.21)
Age-adjusted, sex-adjusted and existing disease-adjusted 1.0 1.15 (1.07 to 1.23) 1.57 (1.45 to 1.69) <0.0001 1.18 (1.15 to 1.21)
Age-adjusted, sex-adjusted and SES-adjusted 1.0 1.23 (1.15 to 1.32) 1.72 (1.59 to 1.85) <0.0001 1.21 (1.18 to 1.24)
Multiply-adjusted 1.0 1.16 (1.08 to 1.25) 1.54 (1.40 to 1.68) <0.0001 1.16 (1.12 to 1.20)
Cancer (2807 deaths)
Age-adjusted and sex-adjusted 1.0 (ref) 1.19 (1.10 to 1.29) 1.59 (1.44 to 1.75) <0.0001 1.17 (1.13 to 1.21)
Age-adjusted, sex-adjusted and neuroticism-adjusted 1.0 1.27 (1.16 to 1.36) 1.90 (1.69 to 2.12) <0.0001 1.25 (1.20 to 1.31)
Age-adjusted, sex-adjusted and health behaviours-adjusted 1.0 1.14 (1.05 to 1.24) 1.38 (1.25 to 1.52) <0.0001 1.10 (1.07 to 1.14)
Age-adjusted, sex-adjusted and physical attributes-adjusted 1.0 1.17 (1.07 to 1.27) 1.50 (1.36 to 1.65) <0.0001 1.14 (1.10 to 1.19)
Age-adjusted, sex-adjusted and existing disease-adjusted 1.0 1.13 (1.04 to 1.23) 1.46 (1.32 to 1.61) <0.0001 1.14 (1.10 to 1.18)
Age-adjusted, sex-adjusted and SES-adjusted 1.0 1.19 (1.09 to 1.30) 1.55 (1.41 to 1.70) <0.0001 1.16 (1.12 to 1.20)
Multiply-adjusted 1.0 1.16 (1.07 to 1.28) 1.54 (1.37 to 1.72) <0.0001 1.15 (1.10 to 1.20)
Cardiovascular disease (890 deaths)
Age-adjusted and sex-adjusted 1.0 (ref) 1.25 (1.08 to 1.46) 1.85 (1.56 to 2.18) <0.0001 1.27 (1.20 to 1.34)
Age-adjusted, sex-adjusted and neuroticism-adjusted 1.0 1.31 (1.12 to 1.54) 2.09 (1.71 to 2.55) <0.0001 1.34 (1.25 to 1.34)
Age-adjusted, sex-adjusted and health behaviours-adjusted 1.0 1.17 (1.00 to 1.36) 1.40 (1.18 to 1.66) <0.0001 1.13 (1.07 to 1.20)
Age-adjusted, sex-adjusted and physical attributes-adjusted 1.0 1.18 (1.01 to 1.37) 1.53 (1.29 to 1.82) <0.0001 1.18 (1.11 to 1.25)
Age-adjusted, sex-adjusted and existing disease-adjusted 1.0 1.13 (0.97 to 1.32) 1.47 (1.24 to 1.75) <0.0001 1.17 (1.10 to 1.24)
Age-adjusted, sex-adjusted and SES-adjusted 1.0 1.26 (1.08 to 1.47) 1.76 (1.48 to 2.08) <0.0001 1.24 (1.17 to 1.31)
Multiply-adjusted 1.0 1.13 (0.96 to 1.32) 1.32 (1.07 to 1.65) 0.009 1.11 (1.03 to 1.20)
External (406 deaths)
Age-adjusted and sex-adjusted 1.0 (ref) 1.17 (0.92 to 1.48) 2.06 (1.62 to 2.62) <0.0001 1.31 (1.21 to 1.41)
Age-adjusted, sex-adjusted and neuroticism-adjusted 1.0 1.16 (0.91 to 1.48) 2.01 (1.51 to 2.69) <0.0001 1.31 (1.20 to 1.34)
Age-adjusted, sex-adjusted and health behaviours-adjusted 1.0 1.12 (0.88 to 1.41) 1.73 (1.35 to 2.21) <0.0001 1.22 (1.12 to 1.32)
Age-adjusted, sex-adjusted and physical attributes-adjusted 1.0 1.13 (0.89 to 1.43) 1.85 (1.45 to 2.37) <0.0001 1.26 (1.16 to 1.36)
Age-adjusted, sex-adjusted and existing disease-adjusted 1.0 1.09 (0.86 to 1.38) 1.77 (1.39 to 2.27) <0.0001 1.24 (1.15 to 1.35)
Age-adjusted, sex-adjusted and SES-adjusted 1.0 1.17 (0.93 to 1.49) 1.97 (1.56 to 2.51) <0.0001 1.28 (1.18 to 1.38)
Multiply-adjusted 1.0 1.06 (0.83 to 1.36) 1.53 (1.14 to 2.06) 0.009 1.17 (1.06 to 1.29)
Multiple adjustment is adjustment for the following covariates: health behaviours (smoking status, alcohol intake frequency, number of types of physical activity performed in last
month, whether five or more portions of fruit and vegetables eaten per day); physical attributes (body mass index, systolic blood pressure, forced expiratory volume in 1 min, grip
strength); existing disease (diagnoses of vascular or heart problems, diabetes, cancer, asthma, chronic lung disease, deep vein thrombosis or pulmonary embolism at baseline) and
socioeconomic status (highest educational qualification).
One SD in psychological distress is 2.0 units; a higher distress category denotes greater distress.
SES, socioeconomic status.
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ﬁgure 1. Finally, we disaggregated the PHQ-4 into its four
component parts (depressed mood, unenthusiasm/disinterest,
tenseness/restlessness and tiredness/lethargy) and related these
to total and CVD mortality (see online supplementary table
S2). The same pattern of association was evident as for the
total distress score.
DISCUSSION
We observed a dose–response relationship between a measure of
psychological distress symptom severity and death from diseases
of public health importance in men and women in a large, con-
temporary and well-characterised cohort study. Neuroticism,
contrary to our prediction, had no explanatory power in this
association.
Study strengths and limitations
We excluded 140 352 participants from our analytical sample
owing to missing data. Relative to the analytical sample, the
excluded group had slightly higher scores for distress (mean
1.87 vs 1.49), and neuroticism (mean 3.78 vs 3.57), and higher
mortality (1.51; 1.45 to 1.58). The distress–total mortality rela-
tion (age-adjusted and sex-adjusted HR per SD increase in dis-
tress; 95% CI) was also somewhat higher (p value for
interaction 0.009) in the excluded group (1.31; 1.27 to 1.34)
than in the analytical sample (1.23; 1.20 to 1.26), suggesting
the HRs in our analytical sample may underestimate the true
levels.
We assessed distress symptoms in the present study using a
very brief inventory, the four-item PHQ, which was designed as
a screening tool rather than a diagnostic device. Investigators on
the largest other study to date to examine the distress–total mor-
tality link administered a more detailed distress questionnaire,1
yet the age-adjusted and sex-adjusted HR per SD increase in dis-
tress (1.21; 1.15 to 1.27) was almost identical to that found in
the present study (1.23; 1.20 to 1.26). Also in accordance with
that study, here we found that the weakest relationship was
apparent for cancer and the strongest for external causes of
death. Additionally, the correlates of scores from the PHQ-4
in the present study—gender, health behaviours, somatic illness
—are similar to those for depression and anxiety, suggesting
some concurrent validity. Taken together, that a single adminis-
tration of a very brief inventory of distress revealed relatively
strong effects may be testimony to the robustness of these
relationships.
Inevitably, we have failed to capture all confounding factors,
or assessed crudely some of those included here. Residual con-
founding is a perennial concern in observational epidemiology
that should, in principle, be circumvented by using the rando-
mised controlled trial design. While it would be unethical to
precipitate prolonged bouts of distress and observe effects on
mortality, an alternative approach is to reverse depression using
a pharmacological and/or spoken therapy and evaluate the
impact of mortality experience, anticipating a lower risk in the
intervention arm. In one of the few such trials conducted, based
on a population of cardiac patients, people successfully treated
for depression did not experience a reduction in event-free sur-
vival relative to the usual care group.9 In a cluster randomised
trial of older people recruited from primary care settings,
however, improved survival was, however, apparent in the treat-
ment arm.10
Finally, the response proportion in UK Biobank, at 10%, is
very low by comparison with other studies. While this has
impact on accurately estimating disease prevalence and inci-
dence—any calculations are likely to be underestimates11—it
has little implications for understating the aetiological role of
risk factors for a given chronic disease for which UK Biobank
was established.12 The original Whitehall study of London-
based, non-industrialised civil servants (raised blood glucose as
a risk factor for heart disease13), the British Doctors’ study of
registered physicians (cigarette smoking and selected cancers14)
and Framingham study based in a single, afﬂuent Massachusetts
town (elevated serum cholesterol as a risk factor for heart
disease15) have all yielded ﬁndings of major public health
importance despite being obviously unrepresentative of the
general population. If a study has a large enough sample and
succeeds in capturing the range of values within the exposure
of interest, the results should be transportable. This logic has
recently been supported by comparing results from an occupa-
tionally based study of civil servants (the second Whitehall
study) with those from the geographically diverse British
Regional Heart Study where near identical HRs across an array
of known risk factors for coronary heart disease were
reported.11 Similarly, in another cohort study, the relation of
risk factor data collected at study induction to future CVD mor-
tality was the same as that in a smaller, select group resurveyed
8 years later.16
Plausible mechanisms
That adjustment for an array of covariates, including neuroti-
cism, did not eliminate the impact of distress on mortality risk
inevitably raises speculation as to other mechanisms that may
explain this relationship. Any such mechanisms are likely to be
outcome-speciﬁc. Thus, bouts of acute anxiety may lead to
acute coronary ischaemia that have been precipitated by coron-
ary vasospasm17 and/or episodic elevations in blood pressure.
Recurrent exposure to emotional disorder may also inhibit
natural killer cell function which is implicated in immune
system function,18 and therefore immunity-related cancers. The
symptoms of fatigue, poor concentration and sleep disturbance,
which characterise even moderately distressed individuals, may
impact unfavourably on decision-making, risk perception,
coordination and response time, so precipitating external causes
of death such as accidents.19
In conclusion, while there was good a priori reasons to antici-
pate the neuroticism would at least partially explain the relation
between distress symptoms and cause-speciﬁc mortality, we
found no such evidence in the present study.
Figure 1 HRs for the full range of psychological distress scores in
relation to total mortality: UK Biobank (N=308 721). PHQ, Patient
Health Questionnaire.
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What is already known on this subject
▸ Meta-analyses of observational studies have shown that
psychological distress (depression and anxiety) is related to
an increased risk of total mortality and cardiovascular
disease.
▸ These gradients seem to be robust to control for various
confounding factors, including health behaviours and
socioeconomic status.
▸ The personality trait of neuroticism, reﬂecting a relatively
stable tendency towards negative emotions, has been
associated with elevated rates of death and cardiovascular
disease in some studies.
What this study adds
▸ For the ﬁrst time, to the best of our knowledge, we tested
the possibility that it is the neuroticism trait itself, rather
than the distress state, that is generating an elevated risk of
mortality.
▸ Using data from UK Biobank, psychological distress was, as
expected, associated with a range of mortality end points.
▸ We found no evidence supporting an explanatory role for
neuroticism; rather, the greatest attenuating effect across
multiple mortality outcomes was apparent for health
behaviours.
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